glutathione in u87mg cells Reduced (GSH) levels were monitored with NRF2 and glutathione are key
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells Oncotarget U87MG vIII 4.12 Glutathione depletion sensitizes cisplatin and temozolomide resistant glioma cells in vitro and in vivo Cell Death & Disease U87MG Cells
Pay in 4 interest-free payments of $5.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21



.jpg)